Skip to main content
. 2012 Oct 31;11:364. doi: 10.1186/1475-2875-11-364

Figure 2.

Figure 2

Kaplan–Meier analysis (intent-to-treat population) showed no difference between pyronaridine-artesunate granules and artemether-lumefantrine crushed tablets for (a) recrudescence rate (P= .53, log-rank test) or (b) re-infection rate (P= .77, log-rank test).